title: Bilateral maculopathy associated with sertraline.
abstract: OBJECTIVE
  We report a rare case of bilateral maculopathy that developed with the initiation of sertraline.
  
  
  METHODS
  We conducted a case report and review of the literature.
  
  
  RESULTS
  A 23-year-old man rapidly developed maculopathy with associated visual blurring after the initiation of sertraline. Treatment was ceased with the patient subsequently reporting mild improvement in visual symptoms.
  
  
  CONCLUSIONS
  Maculopathy associated with sertraline use has yet to be established and recognized as an adverse side effect. With only one previous reported case in the literature, this condition requires further awareness.
authors.affiliation: Tasmanian Eye Institute, Ophthalmology Registrar & Clinical Research Fellow, South Launceston, TAS, Australia shaunewe@gmail.com.
authors.forename: Shaun Y P
authors.initials: SY
authors.lastname: Ewe
authors.affiliation: Tasmanian Eye Institute, Ophthalmology Registrar, South Launceston, TAS, Australia.
authors.forename: Robin G
authors.initials: RG
authors.lastname: Abell
authors.affiliation: Launceston Eye Institute & Tasmanian Eye Institute, Ophthalmologist, South Launceston, TAS, Australia.
authors.forename: Brendan J
authors.initials: BJ
authors.lastname: Vote
mesh_terms: D006801:Humans; D008268:Macular Degeneration / Q000139:chemically induced*; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline / Q000009:adverse effects*; D055815:Young Adult
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline
keywords: drug-induced; maculopathy; ocular toxicity; selective serotonin reuptake inhibitor; sertraline